Chemotherapy for recurrent ovarian cancer-Reference-Cited by-同舟云学术

Chemotherapy for recurrent ovarian cancer

Published:2003-06 Issue:9375 Volume:361 Page:2094-2095
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kaye SB

Publisher

Elsevier BV

Subject

General Medicine

Reference7 articles.

1. Paclitaxel plus carboplatin versus standard chemotherapy with either single agent carboplatin or cyclophosphamide, doxorubicin and cisplatin in women with ovarian cancer: the ICON 3 randomised trial;Lancet,2002

2. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds;Gore;Gynecol Oncol,1990

3. Weekly cisplatin and daily oral etoposide is highly effective in platinum pre-treated ovarian cancer;Van der Burg;B J Cancer,2002

4. Randomised phase II study of carboplatin versus paclitaxel-carboplatin in platinum-sensitive recurrent advanced ovarian cancer: a GEICO study;Gonzalez-Martin;Proc ASCO,2003

5. First-line treatment for advanced ovarian cancer; paclitaxel, platinum and the evidence;Sandercock;B J Cancer,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer;PLOS ONE;2017-08-31

2. MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer;Cancer Science;2017-05

3. Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers;International Journal of Gynecologic Cancer;2011-04

4. Gemcitabine and anthracyclines in platinum-resistant ovarian cancer;Annals of Oncology;2006-05

5. Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study;Annals of Oncology;2005-05